LUNGevity: Team Award Program to Target Mechanisms of Resistance Award (LOI)

To further our knowledge of shared mechanisms of resistance across oncogene-driven LUAD and how they can be targeted using novel pharmaceutical agents. Projects need to address shared mechanisms across 3-4 oncogene driven LUADs. This is a team award and at least two institutions are required to be involved, international teams are highly recommended.

Funding: up to $1.5M for 3 years (No-overhead)

https://www.lungevity.org/research/translational-science-research-award-programs/applying-for-lungevity-award/rising-tide